$37.21 -0.84 (-2.21%)
2/10/2012 4:00 PM

BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 4 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Featured Broker Partners


Advertisement